scholarly article | Q13442814 |
P356 | DOI | 10.1191/0961203304LU525OA |
P698 | PubMed publication ID | 15119545 |
P50 | author | Felix Zintl | Q15453728 |
Paul Emery | Q19859634 | ||
Alois Gratwohl | Q19859713 | ||
Hildegard Greinix | Q47158589 | ||
Jakob R. Passweg | Q67905482 | ||
Nico M Wulffraat | Q90281741 | ||
Dominique Farge | Q90288809 | ||
P2093 | author name string | Peter Schneider | |
Maurizio Musso | |||
Falk Hiepe | |||
Alan Tyndall | |||
Igor Lisukov | |||
Marco Rabusin | |||
Riccardo Saccardi | |||
Alina Ferster | |||
Judith Marsh | |||
Mats Brune | |||
Christoph Fiehn | |||
David Jayne | |||
Antonella Geromin | |||
Alberto Marmont | |||
Renate Arnold | |||
Xiaowu Zhao | |||
Lawrence Faulkner | |||
Athanasios Fassas | |||
Sarah J Bingham | |||
Loic Fouillard | |||
Jian Ou-Yang | |||
Juan Besalduch | |||
European Group for Blood and Marrow Transplantation | |||
European League Against Rheumatism Registry | |||
P433 | issue | 3 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 168-176 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Autologous stem cell transplantation for systemic lupus erythematosus | |
P478 | volume | 13 |
Q52730474 | A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. |
Q39019173 | A big step forward in the treatment of refractory systemic lupus erythematosus: allogenic mesenchymal stem cell transplantation |
Q33614708 | Adult stem cell therapy for autoimmune disease |
Q38041499 | An update on stem cell transplantation in autoimmune rheumatologic disorders |
Q93064412 | Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis |
Q42956411 | Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up. |
Q63214396 | Autologous hematopoietic stem cell transplantation for autoimmune diseases |
Q33632260 | Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. |
Q40545323 | Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus |
Q84409919 | Autologous stem cell transplantation for systemic lupus erythematosus: report of efficacy and safety at 7 years of follow-up in 17 patients |
Q37582300 | Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus |
Q35005506 | Cyclophosphamide and cancer: golden anniversary |
Q46118747 | Depletion of plasma cells - a novel strategy in the therapy of systemic lupus erythematosus in mice and man |
Q36102183 | Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus. |
Q37188496 | Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives |
Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
Q36164087 | Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions |
Q90244356 | Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review |
Q34017756 | Hematopoietic cell transplantation for Crohn's disease; is it time? |
Q38291498 | Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases |
Q37549888 | Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. |
Q58908910 | Hematopoietic stem cell transplantation for systemic lupus erythematosus |
Q34027812 | High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial |
Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
Q95592748 | Lupus nephritis |
Q22000837 | Lupus nephritis: current update |
Q36176635 | Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases |
Q38242079 | Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review |
Q33632194 | Stem cell transplantation for autoimmune diseases |
Q36993217 | Stem cell transplantation for rheumatic autoimmune diseases |
Q33805069 | Stem cell-based cell therapy for glomerulonephritis |
Q58695163 | Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ |
Q38131100 | Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment |
Q36577432 | Systemic lupus erythematosus--2005 annus mirabilis? |
Q37088891 | Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease |
Q39440534 | The potential role of adult stem cells in the management of the rheumatic diseases. |
Q93064417 | Treatment Options for Refractory Lupus Nephritis |
Q33364616 | Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus |
Q51957070 | [Immunoablation followed by autologous stem cell transplantation in lupus: a clinical update]. |
Search more.